Jubilant Life Sciences has reported results for third quarter ended December 31, 2014.
The company has reported a net loss of Rs 8.48 crore for the quarter under review as compared to a net profit of Rs 164.52 crore for the same quarter in the previous year. Total income of the company has decreased by 22.58% at Rs 741.19 crore for Q3FY15 as compared Rs 957.41 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a net loss of Rs 11.16 crore for the Q3 FY15 as compared to a net profit of Rs 143.43 crore in Q3 FY14. However, total income increased 0.21% to Rs 1451.53 crore in the quarter under review as compared to Rs 1448.49 crore in the corresponding quarter previous year.
